TSE (transmissible spongiform encephalopathy) diagnostics top agenda amid new infectivity evidence
This article was originally published in Clinica
There is renewed pressure to find a reliable ante-mortem diagnostic test for transmissible spongiform encephalopathies (TSEs), after UK researchers last week reported the "first conclusive evidence of significant levels of infectivity in blood in a naturally occurring TSE". In light of the evidence, the Department of Health has announced that it is preparing to issue new guidelines to further reduce the risk of secondary transmission of the human TSE, variant Creutzfeldt-Jakob disease (vCJD).
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.